The relationship between albuminuria, MCP-1/CCL2, and interstitial macrophages in chronic kidney disease

Kidney International

Volumn 69, Issue 7, 2006, Pages 1189-1197

  Eardley, K S ^a   Zehnder, D ^b   Quinkler, M ^c   Lepenies, J ^a   Bates, R L ^a   Savage, C O ^d   Howie, A J ^d   Adu, D ^a   Cockwell, P ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b UNIVERSITY OF WARWICK   (United Kingdom)

^c Centre for Internal Medicine Gastroenterology Hepatology and Endocrinology   (Germany)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Albuminuria; Chronic kidney disease; Macrophages; MCP 1 CCL2

Indexed keywords

CREATININE; MONOCYTE CHEMOTACTIC PROTEIN 1;

ALBUMINURIA; ARTICLE; CHRONIC KIDNEY DISEASE; CREATININE URINE LEVEL; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY DISEASE; MACROPHAGE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEINURIA; URINALYSIS;

ALBUMINURIA; CELL COUNT; CHEMOKINE CCL2; CHRONIC DISEASE; DISEASE PROGRESSION; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOHISTOCHEMISTRY; KIDNEY DISEASES; MACROPHAGES;

EID: 33645525811     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5000212     Document Type: Article

References (39)

1. Nath KA. The tubulointerstitium in progressive renal disease. Kidney Int 1998; 54: 992-994.
2. Eardley KS, Cockwell P. Macrophages and progressive tubulointerstitial disease. Kidney Int 2005; 68: 437-455.
3. Hooke DH, Gee DC, Atkins RC. Leucocyte analysis using monoclonal antibodies in human glomerulonephritis. Kidney Int 1987; 31: 964-972.
4. Rodriguez-Iturbe B, Pons H, Herrera-Acosta J, Johnson RJ. Role of immunocompetent cells in nonimmune renal diseases. Kidney Int 2001; 59: 1626-1640.
5. Grandaliano G, Gesualdo L, Ranieri E et al. Monocyte chemotactic peptide-1 expression in acute and chronic human nephritides: a pathogenetic role in interstitial monocytes recruitment. J Am Soc Nephrol 1996; 7: 906-913.
6. Prodjosudjadi W, Gerritsma JS, van Es LA et al. Monocyte chemoattractant protein-1 in normal and diseased human kidneys: an immunohistochemical analysis. Clin Nephrol 1995; 44: 148-155.
7. Yoshimoto K, Wada T, Furuichi K et al. CD68 and MCP-1/CCR2 expression of initial biopsies reflect the outcomes of membranous nephropathy. Nephron Clin Pract 2004; 98: c25-c34.
8. Segerer S, Cui Y, Hudkins KL et al. Expression of the chemokine monocyte chemoattractant protein-1 and its receptor chemokine receptor 2 in human crescentic glomerulonephritis. J Am Soc Nephrol 2000; 11: 2231-2242.
9. Tang WW, Qi M, Warren JS, Van GY. Chemokine expression in experimental tubulointerstitial nephritis. J Immunol 1997; 159: 870-876.
10. Shimizu H, Maruyama S, Yuzawa Y et al. Anti-monocyte chemoattractant protein-1 gene therapy attenuates renal injury induced by protein-overload proteinuria. J Am Soc Nephrol 2003; 14: 1496-1505.
11. Wada T, Furuichi K, Sakai N et al. Gene therapy via blockade of monocyte chemoattractant protein-1 for renal fibrosis. J Am Soc Nephrol 2004; 15: 940-948.
12. Kitagawa K, Wada T, Furuichi K et al. Blockade of CCR2 ameliorates progressive fibrosis in kidney. Am J Pathol 2004; 165: 237-246.
13. Wada T, Furuichi K, Sakai N et al. Up-regulation of monocyte chemoattractant protein-1 in tubulointerstitial lesions of human diabetic nephropathy. Kidney Int 2000; 58: 1492-1499.
14. Morii T, Fujita H, Narita T et al. Increased urinary excretion of monocyte chemoattractant protein-1 in proteinuric renal diseases. Renal Fail 2003; 25: 439-444.
15. Mezzano SA, Droguett MA, Burgos ME et al. Overexpression of chemokines, fibrogenic cytokines, and myofibroblasts in human membranous nephropathy. Kidney Int 2000; 57: 147-158.
16. Burton CJ, Combe C, Walls J, Harris KP. Secretion of chemokines and cytokines by human tubular epithelial cells in response to proteins. Nephrol Dial Transplant 1999; 14: 2628-2633.
17. Wang Y, Chen J, Chen L et al. Induction of monocyte chemoattractant protein-1 in proximal tubule cells by urinary protein. J Am Soc Nephrol 1997; 8: 1537-1545.
18. Lan HY. Tubular epithelial-myofibroblast transdifferentiation mechanisms in proximal tubule cells. Curr Opin Nephrol Hypertens 2003; 12: 25-29.
19. Rose CE, Sung SS, Fu SM. Significant involvement of CCL2 (MCP-1) in inflammatory disorders of the lung. Microcirculation 2003; 10: 273-288.
20. Charo IF, Taubman MB. Chemokines in the pathogenesis of vascular disease. Circ Res 2004; 95: 858-866.
21. Cockwell P, Howie AJ, Adu D, Savage CO. In situ analysis of C-C chemokine mRNA in human glomerulonephritis. Kidney Int 1998; 54: 827-836.
22. Pichler R, Giachelli C, Young B et al. The pathogenesis of tubulointerstitial disease associated with glomerulonephritis: the glomerular cytokine theory. Miner Electrolyte Metab 1995; 21: 317-327.
23. Kluth DC, Rees AJ. New approaches to modify glomerular inflammation. J Nephrol 1999; 12: 66-75.
24. D'Amico G, Bazzi C. Pathophysiology of proteinuria. Kidney Int 2003; 63: 809-825.
25. Hilgers KF, Hartner A, Porst M et al. Monocyte chemoattractant protein-1 and macrophage infiltration in hypertensive kidney injury. Kidney Int 2000; 58: 2408-2419.
26. Schiller B, Moran J. Focal glomerulosclerosis in the remnant kidney model - an inflammatory disease mediated by cytokines. Nephrol Dial Transplant 1997; 12: 430-437.
27. Donadelli R, Abbate M, Zanchi C et al. Protein traffic activates NF-κB gene signaling and promotes MCP-1-dependent interstitial inflammation. Am J Kidney Dis 2000; 36: 1226-1241.
28. Tang S, Leung JC, Tsang AW et al. Transferrin up-regulates chemokine synthesis by human proximal tubular epithelial cells: implication on mechanism of tubuloglomerular communication in glomerulopathic proteinura. Kidney Int 2002; 61: 1655-1665.
29. Sengul S, Zwizinski C, Simon EE et al. Endocytosis of light chains induces cytokines through activation of NF-kappaB in human proximal tubule cells. Kidney Int 2002; 62: 1977-1988.
30. Ghiggeri GM, Ginevri F, Candiano G et al. Characterization of cationic albumin in minimal change nephropathy. Kidney Int 1987; 32: 547-553.
31. Fine LG, Bandyopadhay D, Norman JT. Is there a common mechanism for the progression of different types of renal diseases other than proteinuria? Towards the unifying theme of chronic hypoxia. Kidney Int 2000; 75: S22-S26.
32. Futrakul P, Yenrudi S, Sensirivatana R et al. Renal perfusion and nephronal structure. Nephron 1999; 82: 79-80.
33. Kang DH, Joly AH, Oh SW et al. Impaired angiogenesis in the remnant kidney model: I. Potential role of vascular endothelial growth factor and thrombospondin-1. J Am Soc Nephrol 2001; 12: 1434-1447.
34. Bird JE, Giancarli MR, Kurihara T et al. Increased severity of glomerulonephritis in C-C chemokine receptor 2 knockout mice. Kidney Int 2000; 57: 129-136.
35. Andreesen R, Brugger W, Scheibenbogen C et al. Surface phenotype analysis of human monocyte to macrophage maturation. J Leukoc Biol 2000; 47: 490-497.
36. Furness PN, Rogers-Wheatley L, Harris KP. Semiautomatic quantitation of macrophages in human renal biopsy specimens in proteinuric states. J Clin Pathol 1997; 50: 118-122.
37. Thomas ME, Harris KP, Walls J et al. Fatty acids exacerbate tubulointerstitial injury in protein-overload proteinuria. Am J Physiol Renal Physiol 2002; 283: F640-F647.
38. Howie AJ, Ferreira MA, Adu D. Prognostic value of simple measurement of chronic damage in renal biopsy specimens. Nephrol Dial Transplant 2001; 16: 1163-1169.
39. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1: 307-310.